Ira Horowitz

Evaluation of Monoclonal Humanized Anti-HER2 Antibody, Trastuzumab, in Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma With Overexpression of HER2: A Phase II Trial of the Gynecologic Oncology Group

Michael A. Bookman, Kathleen M. Darcy, Daniel L. Clarke‐Pearson et al. · Journal of Clinical Oncology · 2003 · 610 citations

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

Gini F. Fleming, Michael W. Sill, Kathleen M. Darcy et al. · Gynecologic Oncology · 2009 · 295 citations · Full text

Phase Ii Trial, Medicine, Cancer Management +6

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

Steven J. Skates, Mark H. Greene, Saundra S. Buys et al. · Clinical Cancer Research · 2017 · 135 citations · Full text

Market Definition in Antitrust Analysis: A Regression-Based Approach

Ira Horowitz · Southern Economic Journal · 1981 · 124 citations

Alleged Violations, Economics, Mergers And Acquisitions +13

The Increasing Competitive Balance in Major League Baseball

Ira Horowitz · Review of Industrial Organization · 1997 · 118 citations